» Authors » Sylvain Audia

Sylvain Audia

Explore the profile of Sylvain Audia including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 109
Citations 1648
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Larue M, Moulis G, Rueter M, Audia S, Terriou L, Viallard J, et al.
Blood Adv . 2025 Jan; PMID: 39874521
To assess efficacy and safety of dapsone in adult immune thrombocytopenia (ITP), a multicenter randomized controlled trial (RCT) and a real-word study cohort were performed. Participants were adults with primary...
2.
Razanamahery J, Idbaih A, Papo M, Robelin F, Emile J, Audia S, et al.
Haematologica . 2025 Jan; PMID: 39815815
Not available.
3.
Cottu A, Guillet S, Viallard J, Riviere E, Cheze S, Gobert D, et al.
Blood . 2024 Oct; 145(2):244-247. PMID: 39476101
In an open prospective, multicenter study enrolling 48 selected patients with chronic immune thrombocytopenia who achieved complete response for 1 year on thrombopoietin receptor agonists, half of the patients maintained...
4.
Ramon A, Greigert H, Goueslard K, Cladiere C, Ciudad M, Ornetti P, et al.
RMD Open . 2024 Aug; 10(3). PMID: 39122253
Introduction: Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are frequently overlapping conditions. Unlike in GCA, vascular inflammation is absent in PMR. Therefore, serum biomarkers reflecting vascular remodelling could be...
5.
Hadjadj J, Nguyen Y, Mouloudj D, Bourguiba R, Heiblig M, Aloui H, et al.
Ann Rheum Dis . 2024 May; 83(10):1358-1367. PMID: 38777378
Objectives: Vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic (VEXAS) syndrome is an adult-onset autoinflammatory disease associated with somatic ubiquitin-like modifier-activating enzyme 1 (UBA1) mutations. We aimed to evaluate the efficacy...
6.
Moulis G, Rueter M, Duvivier A, Mahevas M, Viallard J, Comont T, et al.
Br J Haematol . 2024 Jan; 204(4):1476-1482. PMID: 38267268
The aim of this study was to assess the prevalence and the burden of difficult-to-treat primary ITP (pITP), defined by the need for another ITP treatment after romiplostim and eltrombopag....
7.
Guilhem A, Ciudad M, Aubriot-Lorton M, Greigert H, Cladiere C, Leguy-Seguin V, et al.
Front Immunol . 2023 Dec; 14:1321182. PMID: 38143764
Hereditary hemorrhagic telangiectasia (HHT) is a rare inherited disease due to heterozygous loss-of-function mutations on the BMP9/10 pathway ( or mainly). HHT endothelial cells are prone to lose their quiescence,...
8.
Maldiney T, Greigert H, Martin L, Benoit E, Creuzot-Garcher C, Gabrielle P, et al.
PLoS One . 2023 Dec; 18(12):e0296315. PMID: 38113232
[This corrects the article DOI: 10.1371/journal.pone.0234165.].
9.
Greigert H, Ramon A, Genet C, Cladiere C, Gerard C, Cuidad M, et al.
J Autoimmun . 2023 Dec; 142:103151. PMID: 38039746
Vascular smooth muscle cells (VSMCs) have been shown to play a role in the pathogenesis of giant cell arteritis (GCA) through their capacity to produce chemokines recruiting T cells and...
10.
Audia S, Bussel J
Br J Haematol . 2023 Nov; 204(1):24-25. PMID: 37939484
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by isolated thrombocytopenia. Its pathogenesis is complex relying in large part on destruction of platelets recognized by autoantibodies within the spleen....